Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,945,473 | 4,151,515 | 3,738,340 | 3,537,999 | 3,652,090 |
| Marketable Securities | 166,127 | 339,457 | 132,521 | 1,727,152 | 2,955,506 |
| Receivables | 9,360,618 | 10,231,820 | 9,816,614 | 9,245,717 | 9,650,176 |
| Inventories | 7,244,415 | 7,696,951 | 7,394,644 | 7,230,706 | 6,838,962 |
| Other current assets | 3,837 | 78,037 | 75,722 | 76,086 | 94,536 |
| TOTAL | $21,720,470 | $22,497,780 | $21,157,840 | $21,817,660 | $23,191,270 |
| Non-Current Assets | |||||
| PPE Net | 11,791,180 | 11,555,830 | 11,336,180 | 11,352,030 | 11,219,980 |
| Investments And Advances | 1,529,646 | 1,441,065 | 1,453,939 | 1,619,364 | 1,482,729 |
| Intangibles | 28,748,918 | 28,210,018 | 28,312,686 | 28,716,122 | 26,842,123 |
| Other Non-Current Assets | 12,197,556 | 11,793,837 | 11,024,445 | 10,692,624 | 10,660,218 |
| TOTAL | $54,267,300 | $53,000,750 | $52,127,250 | $52,380,140 | $50,205,050 |
| Total Assets | $75,987,770 | $75,498,530 | $73,285,100 | $74,197,800 | $73,396,320 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,001,787 | 3,661,189 | 4,248,229 | 3,317,350 | 3,499,091 |
| Accounts payable and accrued liabilities | 19,596,600 | 18,696,130 | 17,978,620 | 18,540,890 | 19,708,350 |
| Accrued Expenses | 898,364 | 738,741 | 922,595 | 913,032 | 621,950 |
| Other current liabilities | 4,229,849 | 4,813,521 | 2,527,986 | 2,395,441 | 2,377,093 |
| TOTAL | $27,726,600 | $27,909,580 | $25,677,420 | $25,166,710 | $26,206,480 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,704,620 | 17,225,150 | 17,135,530 | 19,219,320 | 18,913,500 |
| Other Non-Current Liabilities | 12,234,994 | 12,324,480 | 12,561,686 | 12,626,474 | 11,912,509 |
| TOTAL | $31,538,570 | $30,091,980 | $30,228,560 | $32,255,390 | $31,274,140 |
| Total Liabilities | $59,265,170 | $58,001,560 | $55,905,980 | $57,422,110 | $57,480,620 |
| Shareholders' Equity | |||||
| Common Shares | 1,722,609 | 1,753,209 | 1,701,311 | 1,709,399 | 1,676,777 |
| Retained earnings | 9,962,509 | 10,648,010 | 10,832,600 | 10,062,370 | 9,004,592 |
| Other shareholders' equity | 599,336 | 578,767 | 463,198 | 602,356 | 941,632 |
| TOTAL | $16,722,600 | $17,496,970 | $17,379,120 | $16,775,700 | $15,915,700 |
| Total Liabilities And Equity | $75,987,770 | $75,498,530 | $73,285,100 | $74,197,810 | $73,396,320 |